CNS vs HASI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 27, 2026

CNS

57.6
AI Score
VS
CNS Wins

HASI

52.7
AI Score

Investment Advisor Scores

CNS

58score
Recommendation
HOLD

HASI

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS HASI Winner
Forward P/E 22.5734 12.5945 HASI
PEG Ratio 2.017 1.2595 HASI
Revenue Growth 12.2% -28.3% CNS
Earnings Growth 31.9% 220.8% HASI
Tradestie Score 57.6/100 52.7/100 CNS
Profit Margin 28.8% 63.7% HASI
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: +6.8% · 3M: +21.2% HASI 1M: -0.5% · 3M: -10.5%

Current Technical Phase

CNS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.4% over 20 days), RSI 64

RSI (14): 64.5 · Price: $83.95

HASI

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -3.4%) with fading momentum, RSI 47

RSI (14): 47.0 · Price: $38.06

Fundamentals Snapshot

Metric CNS HASI
Market Cap
Forward P/E 21.2 11.5
Trailing P/E 25.1 94.9
Revenue (TTM)
Revenue Growth 0.1% -0.3%
Gross Margin 0.5% 1.0%
Operating Margin 0.3% -1.2%
EPS 3.25 0.40
Dividend Yield 0.03% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.